Roche

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Roche and other ETFs, options, and stocks.

About RHHBY

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments.

CEO

Thomas Schinecker

CEOThomas Schinecker

Employees

112,774

Employees112,774

Headquarters

Basel, Basel-Stadt (Basle Town)

HeadquartersBasel, Basel-Stadt (Basle Town)

Founded

1896

Founded1896

Employees

112,774

Employees112,774

RHHBY Key Statistics

Market cap

339.35B

Market cap339.35B

Price-Earnings ratio

22.44

Price-Earnings ratio22.44

Dividend yield

1.57%

Dividend yield1.57%

Average volume

2.83M

Average volume2.83M

High today

$54.49

High today$54.49

Low today

$53.02

Low today$53.02

Open price

$54.34

Open price$54.34

Volume

462.11K

Volume462.11K

52 Week high

$60.85

52 Week high$60.85

52 Week low

$34.75

52 Week low$34.75

RHHBY News

TipRanks 1d

H.C. Wainwright does not see direct read from Roche miss to Olema’s OPERA-02

H.C. Wainwright notes that Roche’s (RHHBY) persevERA trial “disappointingly” failed, though the firm does not view the frontline opportunity as eliminated for p...

Benzinga 2d

Roche's Breast Cancer Drug Falls Short In Phase 3 Study

Roche Holdings AG (OTC:RHHBY) on Monday shared results from the phase 3 persevERA Breast Cancer study of giredestrant combined with palbociclib in advanced canc...

TipRanks 2d

Roche Chairman says diagnostics division exposed to tariffs, Reuters says

Roche (RHHBY) believes that while its agreement with the U.S. government will keep its medicines exempt from the current round of import tariffs, its diagnostic...

Analyst ratings

48%

of 23 ratings

Buy

47.8%

Hold

39.1%

Sell

13%

More RHHBY News

Seeking Alpha 3d

Roche continues to expect tariff impact on diagnostics despite U.S. deal

Roche (RHHBY) expects its diagnostics division to remain exposed to the Trump administration’s tariffs despite a recent U.S. pricing deal that gave a three-year...

Benzinga 5d

Roche's Obesity Drug Shows Promise But Trails GLP-1 Giants Novo Nordisk, Eli Lilly

Genentech on Thursday shared topline results from the Phase 2 ZUPREME-1 trial evaluating petrelintide versus placebo in 493 obese participants (mean BMI of 37 k...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.